Home » Topics » Regulatory

Regulatory
RSS

Phase I study of pentosan polysulfate in cancer patients

Feb. 25, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Centocor seeks expansion of ReoPro indications

Feb. 21, 1997

Transdermal buspirone pivotal trials

Feb. 21, 1997

Schering-Plough seeks FDA approval for psoriasis treatment

Feb. 20, 1997

Antidepressant with minimal impact on sexual function introduced

Feb. 18, 1997

Immunomedics' LeukoScan approved for European market

Feb. 18, 1997

New dosage strengths of Coumadin available

Feb. 18, 1997

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.